Assets Изменить Дата
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Exelixis USD 2.98B 165.56M 2023-09
Immunic USD 66.98M 21.76M 2023-09
Incyte USD 6.78B 393.87M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Xoma USD 124.09M 1.57M 2023-09



Prothena Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.